These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3884010)

  • 1. Inactivation of bradykinin and kallidin by cathepsin G and mast cell chymase.
    Reilly CF; Schechter NB; Travis J
    Biochem Biophys Res Commun; 1985 Mar; 127(2):443-9. PubMed ID: 3884010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin I conversion by human and rat chymotryptic proteinases.
    Wintroub BU; Schechter NB; Lazarus GS; Kaempfer CE; Schwartz LB
    J Invest Dermatol; 1984 Nov; 83(5):336-9. PubMed ID: 6092480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of the primary structures of human skin chymase and cathepsin G from cutaneous mast cells of urticaria pigmentosa lesions.
    Schechter NM; Wang ZM; Blacher RW; Lessin SR; Lazarus GS; Rubin H
    J Immunol; 1994 Apr; 152(8):4062-9. PubMed ID: 8144971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a cathepsin G-like proteinase in the MCTC type of human mast cell.
    Schechter NM; Irani AM; Sprows JL; Abernethy J; Wintroub B; Schwartz LB
    J Immunol; 1990 Oct; 145(8):2652-61. PubMed ID: 2212656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid conversion of angiotensin I to angiotensin II by neutrophil and mast cell proteinases.
    Reilly CF; Tewksbury DA; Schechter NM; Travis J
    J Biol Chem; 1982 Aug; 257(15):8619-22. PubMed ID: 6807977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The inhibition of mast cell activation by neutrophil lactoferrin: uptake by mast cells and interaction with tryptase, chymase and cathepsin G.
    He S; McEuen AR; Blewett SA; Li P; Buckley MG; Leufkens P; Walls AF
    Biochem Pharmacol; 2003 Mar; 65(6):1007-15. PubMed ID: 12623133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammalian chymotrypsin-like enzymes. Comparative reactivities of rat mast cell proteases, human and dog skin chymases, and human cathepsin G with peptide 4-nitroanilide substrates and with peptide chloromethyl ketone and sulfonyl fluoride inhibitors.
    Powers JC; Tanaka T; Harper JW; Minematsu Y; Barker L; Lincoln D; Crumley KV; Fraki JE; Schechter NM; Lazarus GG
    Biochemistry; 1985 Apr; 24(8):2048-58. PubMed ID: 3893542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Action of two thiol proteinases from the spleen which are active in neutral media on vasoactive peptides].
    Lokshina LA; Egorova TP; Orekhovich VN
    Biokhimiia; 1983 Jun; 48(6):951-8. PubMed ID: 6349701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expansion of the mast cell chymase locus over the past 200 million years of mammalian evolution.
    Gallwitz M; Reimer JM; Hellman L
    Immunogenetics; 2006 Aug; 58(8):655-69. PubMed ID: 16807745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of substance P and bradykinin by human neutrophils.
    Skidgel RA; Jackman HL; Erdös EG
    Biochem Pharmacol; 1991 May; 41(9):1335-44. PubMed ID: 1708255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mastocyte proteinase].
    Olejnik AK; Brzezińska-Błaszczyk E
    Postepy Hig Med Dosw; 1998; 52(4):381-99. PubMed ID: 9780758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human mast cell chymase gene (CMA1): mapping to the cathepsin G/granzyme gene cluster and lineage-restricted expression.
    Caughey GH; Schaumberg TH; Zerweck EH; Butterfield JH; Hanson RD; Silverman GA; Ley TJ
    Genomics; 1993 Mar; 15(3):614-20. PubMed ID: 8468056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid lineage-specific diversification of the mast cell chymase locus during mammalian evolution.
    Gallwitz M; Hellman L
    Immunogenetics; 2006 Aug; 58(8):641-54. PubMed ID: 16807746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II generation by mast cell alpha- and beta-chymases.
    Caughey GH; Raymond WW; Wolters PJ
    Biochim Biophys Acta; 2000 Jul; 1480(1-2):245-57. PubMed ID: 10899625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mast cells and neutrophils proteolytically activate chemokine precursor CTAP-III and are subject to counterregulation by PF-4 through inhibition of chymase and cathepsin G.
    Schiemann F; Grimm TA; Hoch J; Gross R; Lindner B; Petersen F; Bulfone-Paus S; Brandt E
    Blood; 2006 Mar; 107(6):2234-42. PubMed ID: 16317101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel, potent dual inhibitor of the leukocyte proteases cathepsin G and chymase: molecular mechanisms and anti-inflammatory activity in vivo.
    de Garavilla L; Greco MN; Sukumar N; Chen ZW; Pineda AO; Mathews FS; Di Cera E; Giardino EC; Wells GI; Haertlein BJ; Kauffman JA; Corcoran TW; Derian CK; Eckardt AJ; Damiano BP; Andrade-Gordon P; Maryanoff BE
    J Biol Chem; 2005 May; 280(18):18001-7. PubMed ID: 15741158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility of soluble and matrix fibronectins to degradation by tissue proteinases, mast cell chymase and cathepsin G.
    Vartio T; Seppä H; Vaheri A
    J Biol Chem; 1981 Jan; 256(1):471-7. PubMed ID: 6450204
    [No Abstract]   [Full Text] [Related]  

  • 18. Human neutrophil and mast cell proteases implicated in inflammation.
    Rest RF
    Methods Enzymol; 1988; 163():309-27. PubMed ID: 3070298
    [No Abstract]   [Full Text] [Related]  

  • 19. Albumin is a substrate of human chymase. Prediction by combinatorial peptide screening and development of a selective inhibitor based on the albumin cleavage site.
    Raymond WW; Ruggles SW; Craik CS; Caughey GH
    J Biol Chem; 2003 Sep; 278(36):34517-24. PubMed ID: 12815038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human chymase.
    Schechter NM
    Monogr Allergy; 1990; 27():114-31. PubMed ID: 2084534
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.